12.34MUSD
See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US0547548745
CUSIP
054754205
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
June
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
5.66
Dividend Share
-
Dividend Yield
-
Earnings Share
-1.49
Wall Street Target Price
8.00
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
77,691,000
Gross Profit TTM
51,559,000
EBITDA
6,481,000
Profit Margin
2.11%
Return On Assets TTM
-0.16%
Return On Equity TTM
-1.23%
Revenue Per Share TTM
12.974
Qtly Revenue Growth YOY
2.60%
Diluted Eps TTM
-1.49
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
1
Price Sales TTM
0.1612
Price Book MRQ
0.3589
Enterprise Value Revenue
0
Enterprise Value EBITDA
1
48.69
1.18%11.07
0.45%14.32
0.42%120.50
0.00%16.11
0.00%26.30
0.00%130.47
-4.20%16.55
-1.40%161.44
-1.36%26.44
-0.04%